COMMUNIQUÉS West-GlobeNewswire

Medovex Corporation’s DenerveX System Demonstrates Clinical Benefits in Patients Suffering from Low Back Facet Joint Pain
02/07/2018
Review of Real World Cases from Five Independent Sites Across Europe Demonstrated Reduction in Pain Scores and General Improvement of Health Metrics up to 6 Months Following Treatment as Evidenced by VAS BACK , ODI and [...]
SeaSpine Names Dennis L. Cirino Senior Vice President, Spinal Systems
02/07/2018
CARLSBAD, Calif., July 02, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced [...]
Novo Nordisk A/S - Share repurchase programme
02/07/2018
Bagsværd, Denmark, 2 July 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR), [...]
Nuvectra Provides Update on FDA and TÜV SÜD Review of Virtis™ PMA and CE Mark Applications
02/07/2018
PLANO, Texas, July 02, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, today provided an update on its U.S. Food and Drug Administration (FDA) pre-market approval [...]
Conatus Pharmaceuticals’ Pan-caspase Inhibitor Emricasan Improves Survival and Portal Hypertension in a Mouse Model of Cirrhosis
02/07/2018
SAN DIEGO, July 02, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced the publication 1 of results from preclinical studies of its pan-caspase inhibitor emricasan, demonstrating [...]
Transactions under Novozymes’ stock buyback program
02/07/2018
Please read the full announcement in the attached PDF Attachment 2018_41_Stock_Buybackprogram_EN
BrightGuard Installs Free Sunscreen Dispensers at New York City Public Pools and Beaches
02/07/2018
First-of-its-Kind Automated Sunscreen Dispenser Company Teams with Coppertone® and IMPACT Melanoma to Provide Free, High-Quality Sunscreen to Help Reduce NYC’s Risk of Skin Cancer NEW YORK and NEWPORT BEACH, Calif., [...]
RedHill Biopharma Announces Allowance of Two New RHB-104 Patents Ahead of Top-Line Phase III Results for Crohn’s Disease
02/07/2018
RedHill has received Notices of Allowance for two new patents covering RHB-104 in the U.S. and Europe which are expected to be valid until at least 2029, once granted Top-line results from the first Phase III study with [...]
Athenex Announces Pipeline Expansion Initiatives in Conjunction with a Strategic Investment of $100 million by Perceptive Advisors
02/07/2018
Collaboration with Xiangxue Pharmaceutical Expands Portfolio in to TCR-T Immunotherapy In-Licensing of a Biologic Product from Avalon BioMedical Management BUFFALO, N.Y., July 02, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc [...]
PotNetwork Holdings, Inc. Changing Name To Biotech Hemp, Inc. and Moves Forward on Filings In Preparation for Uplisting
02/07/2018
Company to Rapidly Complete FINRA Application, and Form 10 To Become Fully Reporting SEC Issuer FT LAUDERDALE, Fla., July 02, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork Holdings, Inc. (OTC Pink:POTN) [...]
Mesoblast Enters Into US$50M Financing with Novaquest Capital for Commercial Readiness of Remestemcel-l in the Treatment of Acute Graft Versus Host Disease
02/07/2018
NEW YORK and MELBOURNE, Australia, July 02, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) today announced a US$50 million financing from NovaQuest Capital Management, L.L.C. (NovaQuest) for the [...]
Arrayit Corporation Completes Allergy Testing Pilot Program for One of the Nation’s Largest Retail Chains
02/07/2018
Sunnyvale, July 02, 2018 (GLOBE NEWSWIRE) -- July 2, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces that the company has completed an allergy [...]
Opthea’s Phase 2b Wet AMD Clinical Trial Reaches Mid-Way Point of Patient Recruitment
02/07/2018
Opthea Recruits 176th Patient and On-Track to Report Primary Data Analysis Early 2020 MELBOURNE, Australia, July 02, 2018 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT), a late stage biopharmaceutical company developing [...]
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants
02/07/2018
FIT Biotech Oy Company release July 2, 2018 at 10:30 am EET FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants On December 22, 2017, the Board of Directors of FIT Biotech Oy ( [...]
Dr. Deborah Dunsire named new President and CEO of Lundbeck
02/07/2018
Valby, Denmark, 2 July 2018 - H. Lundbeck A/S (Lundbeck) today announced that the Board of Directors of the company has appointed Dr. Deborah Dunsire as new president and CEO of Lundbeck. Dr. Dunsire will take up her [...]
Solon Eiendom ASA : Sales in Q2 2018
02/07/2018
Oslo, July 2, 2018 - Solon Eiendom sold 107 homes with a total sales value of NOK 733 million during the second quarter of 2018 compared to 68 homes with a total sales value of NOK 685 million in the second quarter of [...]
Dr. Deborah Dunsire named new President and CEO of Lundbeck
02/07/2018
Valby, Denmark, 2 July 2018 - H. Lundbeck A/S (Lundbeck) today announced that the Board of Directors of the company has appointed Dr. Deborah Dunsire as new president and CEO of Lundbeck. Dr. Dunsire will take up her [...]
Solon Eiendom ASA : Primary insider notification
02/07/2018
(Oslo, Norway, June 29, 2018) UFI AS has today bought 2.490 shares in Solon Eiendom ASA at a price of NOK 30.10 per share. Solon Eiendom ASA Board Member Øystein A. Landvik owns 33,34 % of the shares in UFI AS. [...]
NOTICE OF BIOHIT OYJ’S EXTRAORDINARY GENERAL MEETING
02/07/2018
Biohit Oyj Stock Exchange Release July 2, 2018 at 9:30 am local time (EEST) Biohit Oyj shareholders are invited to attend the Extraordinary General Meeting of Biohit Oyj to be held on Thursday, August 16, 2018 starting [...]

Pages